Middle East Molecular Point of Care Testing (Using NAAT) Market Scope, Research Report Forecast

Description

Middle East molecular point of care testing (using NAAT) Market  is expected to reach USD 2,175.21 million by 2028, from USD 1,121.37 million in 2020, growing at the CAGR of 7.4% in the forecast period of 2021 to 2028.In the global pandemic, attempt to synergize the sensitivity of NAATs and the ease of use of POCT assays, miniaturized NAAT-based POCT devices and assays were devised for faster screening and diagnosis of COVID-19, which also propelled the growth of the Market .

Market  Analysis and Insights: Middle East Molecular Point of Care Testing (Using NAAT) Market

POCT is characterized as testing which can be done close to the patient where a medical decision can be made immediately, including the results and monitoring. POCT devices now entering into clinical use are based on nucleic acid amplification technologies (NAAT), defined here as second-generation devices. These platforms generally have improved sensitivity, typically in the range of 60 to 90%, compared to first-generation POCTs, and require portable instrumentation with a footprint of approximately 30cm x 30cm. These instruments are essentially used in the molecular detection of various disorders such as HIV, HPV, and respiratory disease through NAAT technology. NAAT is Nucleic Acid Amplification Techniques which allows identification of pathogenic organisms by detecting their DNA or RNA.

Molecular point-of-care testing's significant advantages include the rapid diagnosis process, treatment choice, monitoring, and prognosis. This will also help in operational decision-making and proper resource utilization. The increasing prevalence of chronic disease and increasing diagnosis-seeking rate are expected to act as drivers for the Market . However, the high cost of POCT instruments may hinder the growth of the Market .

This Middle East molecular point of care testing (using NAAT) Market  report provides details of Market  share, new developments, and product pipeline analysis, the impact of domestic and localized Market  players, analyses opportunities in terms of emerging revenue pockets, changes in Market  regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the Market . To understand the analysis and the Market  scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.

Request Access for Middle East Molecular Point of Care Testing (Using NAAT) Market

Sample Report:  https://www.databridgeMarket research.com/request-a-sample/?dbmr=middle-east-molecular-point-of-care-testing-using-naat-Market   

Middle East Molecular Point Of Care Testing (Using NAAT) Market  Scope and Market  Size

·   On the basis of indication, the Middle East molecular point of care testing (using NAAT) Market  is segmented into sexually transmitted infection (STI) testing, respiratory infection testing, gastrointestinal tract infection testing, and others. In 2021, the respiratory segment in the molecular point of care testing (using NAAT) Market  is expected to dominate because of a sudden outbreak of COVID-19 and a rise in the incidence of various other respiratory disorders due to the no-contact spread of the disease.

·   On the basis of product, the Middle East molecular point of care testing (using NAAT) Market  is segmented into instruments, consumables and reagents. In 2021, the consumables & reagents segment in the molecular point of care testing (using NAAT) Market  is expected to grow due to the increasing demand for the product of molecular POCT in this region.

·   On the basis of end user, the Middle East molecular point of care testing (using NAAT) Market  is segmented into laboratories, hospitals, clinics, ambulatory centers, home care, assisted living facilities, and others. In 2021, the laboratories segment is expected to dominate the Market  because the major laboratories around the world are expanding their research and medical laboratories to upgrade the medical facilities.

·   On the basis of mode of testing, the Middle East molecular point of care testing (using NAAT) Market  is segmented into prescription-based testing and OTC testing. In 2021, the prescription-based testing segment in the molecular point of care testing (using NAAT) Market  is expected to grow because the use of NAAT in PCOT is new and thus requires expert advice and monitoring, which increase the Market  for prescription-based testing.

·   On the basis of distribution channel, the Middle East molecular point of care testing (using NAAT) Market  is segmented into direct tender, third party distributor, online sales. In 2021, the direct sales segment in the molecular point of care testing (using NAAT) Market  is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.

Get TOC of the Report: https://www.databridgeMarket research.com/toc/?dbmr=middle-east-molecular-point-of-care-testing-using-naat-Market  

Major TOC of the Middle East Molecular Point of Care Testing (Using NAAT) Market Report

Chapter One:

MARKET  SEGEMENTATION

EXECUTIVE SUMMARY  

PREMIUM INSIGHTS

MARKET  OVERVIEW

Access Full Report:- https://www.databridgeMarket research.com/reports/middle-east-molecular-point-of-care-testing-using-naat-Market   

Middle East Molecular Point of Care Testing (Using NAAT) Market  Country Level Analysis

The country section of the report also provides individual Market  impacting factors and changes in regulation in the Market  domestically that impact the current and future trends of the Market . Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the Market  scenario for individual countries. Also, the presence and availability of Middle East brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data. 

Competitive Landscape and Molecular Point of Care Testing (Using NAAT) Market  Share Analysis

 Details included are company overview, company financials, revenue generated, Market  potential, investment in research and development, new Market  initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to Middle East molecular point of care testing (using NAAT).

The major companies providing molecular point of care testing (using NAAT) products in the Middle East molecular point of care testing (using NAAT) Market  are

·       ABBOTT,

·       Hologic, Inc.,

·       F.Hoffmann-La Roche Ltd.,

·       Meridian Bioscience,

·       Quantumdx Group Ltd.,

·       Cardinal Health,

·       biomerieux SA,

·       Bio-Rad Laboratories, Inc.,

·       GenMark Diagnsotics, Inc.,

·       Grifols, S.A.,

·       QIAGEN,

·       Quidel Corporation,

·       SD Biosensor, INC.,

·       Seegene Inc., among others.

Browse Related Reports @

Middle East and Africa Ethylene-Vinyl Alcohol Copolymer (EVOH) Packaging Films Market

Global Commercial Dishwashers Market

Europe Commercial Dishwashers Market

U.S. Private Label Food and Beverages Market

Europe Point-Of-Care-Testing (POCT) Market

Thailand Point-of-Care Testing (POCT) Market

About Us:

Data Bridge Market  Research set forth itself as an unconventional and neoteric Market  research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market  opportunities and foster efficient information for your business to thrive in the Market

 Contact:

Data Bridge Market  Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgeMarket research.com